Somatic gene transfer to the adult primate central nervous system

In vitro and in vivo characterization of cells genetically modified to secrete nerve growth factor

Mark H. Tuszynski, Marie Claude Senut, Jasodhara Ray, Jeffrey A Roberts, Hoi Sang U, Fred H. Gage

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Somatic gene transfer offers a means of delivering substances to the central nervous system (CNS) in a regionally specific, high-dose, chronic and well-tolerated manner. Studies in rats have shown that genetically modified cell grafts can prevent neuronal degeneration and promote functional recovery after injury and can improve cognitive function in aged subjects. To assess the potential utility of somatic gene transfer techniques in primate models, retroviral vectors were used to modify genetically monkey and human primary skin fibroblasts to produce and secrete human nerve growth factor (NGF). In vitro, all cell types produced NGF and sustained this production through cell growth to confluency, as determined by both Northern blot analysis and ELISA. Adult human fibroblasts produced as much NGF as did young human fibroblasts. Monkey fibroblasts genetically modified to produce NGF were then grafted to intact adult rhesus and cynomolgous monkey brains. Among nine primates that received a total of 76 grafts, surviving cells were found in all subjects up to the maximal experimental timepoint of 6 months. Cholinergic fibres from the host brain penetrated NGF-secreting grafts up to 6 months after grafting, but showed little penetration in control grafts lacking the NGF gene. Autografts survived better than allografts. These findings indicate that both human and primate fibroblasts can be transduced to produce and secrete NGF, can maintain this production whether in a growing or quiescent state and can elicit robust sprouting responses when primate fibroblasts are grafted to the adult brain. Cells genetically modified to produce trophic factors are a useful model for studying in vitro and in vivo CNS plasticity and for testing potential therapies for neurodegenerative conditions.

Original languageEnglish (US)
Pages (from-to)67-78
Number of pages12
JournalNeurobiology of Disease
Volume1
Issue number1-2
StatePublished - 1994

Fingerprint

Nerve Growth Factor
Primates
Central Nervous System
Fibroblasts
Genes
Transplants
Haplorhini
Brain
Cholinergic Fibers
Gene Transfer Techniques
Autografts
In Vitro Techniques
Macaca mulatta
Northern Blotting
Cognition
Allografts
Enzyme-Linked Immunosorbent Assay
Skin
Wounds and Injuries
Growth

Keywords

  • Cholinergic neurones
  • Gene therapy
  • Nerve growth factor
  • Retroviral vectors

ASJC Scopus subject areas

  • Neurology

Cite this

Somatic gene transfer to the adult primate central nervous system : In vitro and in vivo characterization of cells genetically modified to secrete nerve growth factor. / Tuszynski, Mark H.; Senut, Marie Claude; Ray, Jasodhara; Roberts, Jeffrey A; U, Hoi Sang; Gage, Fred H.

In: Neurobiology of Disease, Vol. 1, No. 1-2, 1994, p. 67-78.

Research output: Contribution to journalArticle

@article{8d8b87ef80794cabbcb7aca5a4e71f36,
title = "Somatic gene transfer to the adult primate central nervous system: In vitro and in vivo characterization of cells genetically modified to secrete nerve growth factor",
abstract = "Somatic gene transfer offers a means of delivering substances to the central nervous system (CNS) in a regionally specific, high-dose, chronic and well-tolerated manner. Studies in rats have shown that genetically modified cell grafts can prevent neuronal degeneration and promote functional recovery after injury and can improve cognitive function in aged subjects. To assess the potential utility of somatic gene transfer techniques in primate models, retroviral vectors were used to modify genetically monkey and human primary skin fibroblasts to produce and secrete human nerve growth factor (NGF). In vitro, all cell types produced NGF and sustained this production through cell growth to confluency, as determined by both Northern blot analysis and ELISA. Adult human fibroblasts produced as much NGF as did young human fibroblasts. Monkey fibroblasts genetically modified to produce NGF were then grafted to intact adult rhesus and cynomolgous monkey brains. Among nine primates that received a total of 76 grafts, surviving cells were found in all subjects up to the maximal experimental timepoint of 6 months. Cholinergic fibres from the host brain penetrated NGF-secreting grafts up to 6 months after grafting, but showed little penetration in control grafts lacking the NGF gene. Autografts survived better than allografts. These findings indicate that both human and primate fibroblasts can be transduced to produce and secrete NGF, can maintain this production whether in a growing or quiescent state and can elicit robust sprouting responses when primate fibroblasts are grafted to the adult brain. Cells genetically modified to produce trophic factors are a useful model for studying in vitro and in vivo CNS plasticity and for testing potential therapies for neurodegenerative conditions.",
keywords = "Cholinergic neurones, Gene therapy, Nerve growth factor, Retroviral vectors",
author = "Tuszynski, {Mark H.} and Senut, {Marie Claude} and Jasodhara Ray and Roberts, {Jeffrey A} and U, {Hoi Sang} and Gage, {Fred H.}",
year = "1994",
language = "English (US)",
volume = "1",
pages = "67--78",
journal = "Neurobiology of Disease",
issn = "0969-9961",
publisher = "Academic Press Inc.",
number = "1-2",

}

TY - JOUR

T1 - Somatic gene transfer to the adult primate central nervous system

T2 - In vitro and in vivo characterization of cells genetically modified to secrete nerve growth factor

AU - Tuszynski, Mark H.

AU - Senut, Marie Claude

AU - Ray, Jasodhara

AU - Roberts, Jeffrey A

AU - U, Hoi Sang

AU - Gage, Fred H.

PY - 1994

Y1 - 1994

N2 - Somatic gene transfer offers a means of delivering substances to the central nervous system (CNS) in a regionally specific, high-dose, chronic and well-tolerated manner. Studies in rats have shown that genetically modified cell grafts can prevent neuronal degeneration and promote functional recovery after injury and can improve cognitive function in aged subjects. To assess the potential utility of somatic gene transfer techniques in primate models, retroviral vectors were used to modify genetically monkey and human primary skin fibroblasts to produce and secrete human nerve growth factor (NGF). In vitro, all cell types produced NGF and sustained this production through cell growth to confluency, as determined by both Northern blot analysis and ELISA. Adult human fibroblasts produced as much NGF as did young human fibroblasts. Monkey fibroblasts genetically modified to produce NGF were then grafted to intact adult rhesus and cynomolgous monkey brains. Among nine primates that received a total of 76 grafts, surviving cells were found in all subjects up to the maximal experimental timepoint of 6 months. Cholinergic fibres from the host brain penetrated NGF-secreting grafts up to 6 months after grafting, but showed little penetration in control grafts lacking the NGF gene. Autografts survived better than allografts. These findings indicate that both human and primate fibroblasts can be transduced to produce and secrete NGF, can maintain this production whether in a growing or quiescent state and can elicit robust sprouting responses when primate fibroblasts are grafted to the adult brain. Cells genetically modified to produce trophic factors are a useful model for studying in vitro and in vivo CNS plasticity and for testing potential therapies for neurodegenerative conditions.

AB - Somatic gene transfer offers a means of delivering substances to the central nervous system (CNS) in a regionally specific, high-dose, chronic and well-tolerated manner. Studies in rats have shown that genetically modified cell grafts can prevent neuronal degeneration and promote functional recovery after injury and can improve cognitive function in aged subjects. To assess the potential utility of somatic gene transfer techniques in primate models, retroviral vectors were used to modify genetically monkey and human primary skin fibroblasts to produce and secrete human nerve growth factor (NGF). In vitro, all cell types produced NGF and sustained this production through cell growth to confluency, as determined by both Northern blot analysis and ELISA. Adult human fibroblasts produced as much NGF as did young human fibroblasts. Monkey fibroblasts genetically modified to produce NGF were then grafted to intact adult rhesus and cynomolgous monkey brains. Among nine primates that received a total of 76 grafts, surviving cells were found in all subjects up to the maximal experimental timepoint of 6 months. Cholinergic fibres from the host brain penetrated NGF-secreting grafts up to 6 months after grafting, but showed little penetration in control grafts lacking the NGF gene. Autografts survived better than allografts. These findings indicate that both human and primate fibroblasts can be transduced to produce and secrete NGF, can maintain this production whether in a growing or quiescent state and can elicit robust sprouting responses when primate fibroblasts are grafted to the adult brain. Cells genetically modified to produce trophic factors are a useful model for studying in vitro and in vivo CNS plasticity and for testing potential therapies for neurodegenerative conditions.

KW - Cholinergic neurones

KW - Gene therapy

KW - Nerve growth factor

KW - Retroviral vectors

UR - http://www.scopus.com/inward/record.url?scp=0028535645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028535645&partnerID=8YFLogxK

M3 - Article

VL - 1

SP - 67

EP - 78

JO - Neurobiology of Disease

JF - Neurobiology of Disease

SN - 0969-9961

IS - 1-2

ER -